Beam Therapeutics to Participate in the 43rd Annual Cowen
CAMBRIDGE, Mass., March 01, 2023 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company
Globe Newswire1-03-2023, 18:36
OKX Launches 'Web3 DeFi Bonus Season' Campaign, Giving Users the Opportunity to Earn an Additional APR of Up to 14% 20-11-2023, 14:15